{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T18:09:38Z","timestamp":1764785378193,"version":"3.37.3"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T00:00:00Z","timestamp":1713744000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["K23 DA047475"],"award-info":[{"award-number":["K23 DA047475"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence Reports"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.dadr.2024.100235","type":"journal-article","created":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T16:55:41Z","timestamp":1713977741000},"page":"100235","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["The effect of a pilot brief educational intervention on preferences regarding treatments for opioid use disorder"],"prefix":"10.1016","volume":"11","author":[{"given":"Emaun","family":"Irani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colin","family":"Macleod","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Slat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrianne","family":"Kehne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin","family":"Madden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaitlyn","family":"Jaffe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy","family":"Bohnert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pooja","family":"Lagisetty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.dadr.2024.100235_bib1","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1176\/appi.ajp.2020.20091293","article-title":"Sustained Effect of a Brief Video in Reducing Public Stigma Toward Individuals With Psychosis: A Randomized Controlled Trial of Young Adults","volume":"178","author":"Amsalem","year":"2021","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.dadr.2024.100235_bib2","first-page":"59","article-title":"Medications for opioid use disorder: a guide for physicians","volume":"117","author":"Azhar","year":"2020","journal-title":"Mo Med"},{"key":"10.1016\/j.dadr.2024.100235_bib3","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jsat.2013.04.002","article-title":"Perceived relapse risk and desire for medication assisted treatment among persons seeking inpatient opiate detoxification","volume":"45","author":"Bailey","year":"2013","journal-title":"J. Subst. Abus. Treat."},{"key":"10.1016\/j.dadr.2024.100235_bib4","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.pedn.2019.10.005","article-title":"Stigma associated with opioid use disorders in adolescents limits naloxone prescribing","volume":"49","author":"Carson","year":"2019","journal-title":"J. Pediatr. Nurs."},{"key":"10.1016\/j.dadr.2024.100235_bib5","unstructured":"CDC, 2022. Overdose Deaths Rise, Disparities Widen [WWW Document]. Cent. Dis. Control Prev. URL \u3008https:\/\/www.cdc.gov\/vitalsigns\/overdose-death-disparities\/index.html\u3009 (accessed 4.4.23)."},{"key":"10.1016\/j.dadr.2024.100235_bib6","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1016\/j.drugpo.2013.04.004","article-title":"Substance, structure and stigma: parents in the UK accounting for opioid substitution therapy during the antenatal and postnatal periods","volume":"24","author":"Chandler","year":"2013","journal-title":"Int J. Drug Policy"},{"key":"10.1016\/j.dadr.2024.100235_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2020.108146","article-title":"A systematic review of patients\u2019 and providers\u2019 perspectives of medications for treatment of opioid use disorder","volume":"119","author":"Cioe","year":"2020","journal-title":"J. Subst. Abus. Treat."},{"key":"10.1016\/j.dadr.2024.100235_bib8","doi-asserted-by":"crossref","unstructured":"Committee on Medication-Assisted Treatment for Opioid Use Disorder, Board on Health Sciences Policy, Health and Medicine Division, National Academies of Sciences, Engineering, and Medicine, 2019. Medications for Opioid Use Disorder Save Lives. National Academies Press, Washington, D.C. \u3008https:\/\/doi.org\/10.17226\/25310\u3009","DOI":"10.17226\/25310"},{"key":"10.1016\/j.dadr.2024.100235_bib9","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41597-023-01947-0","article-title":"Validated names for experimental studies on race and ethnicity","volume":"10","author":"Crabtree","year":"2023","journal-title":"Sci. Data"},{"key":"10.1016\/j.dadr.2024.100235_bib10","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jsat.2018.10.006","article-title":"Evidence-based treatment for opioid use disorders: A national study of methadone dose levels, 2011\u20132017","volume":"96","author":"D\u2019Aunno","year":"2019","journal-title":"J. Subst. Abus. Treat."},{"key":"10.1016\/j.dadr.2024.100235_bib11","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.jss.2021.10.005","article-title":"Using tailored messages to target overuse of low-value breast cancer care in older women","volume":"270","author":"Dossett","year":"2022","journal-title":"J. Surg. Res"},{"key":"10.1016\/j.dadr.2024.100235_bib12","first-page":"71","article-title":"CDC clinical practice guideline for prescribing opioids for pain \u2014 United States, 2022","author":"Dowell","year":"2022","journal-title":"MMWR Recomm. Rep."},{"key":"10.1016\/j.dadr.2024.100235_bib13","unstructured":"Dydyk, A.M., Jain, N.K., Gupta, M., 2023. Opioid Use Disorder, in: StatPearls. StatPearls Publishing, Treasure Island (FL)."},{"key":"10.1016\/j.dadr.2024.100235_bib14","unstructured":"Dynata, 2023. Dynata\u2019s World Class Quality. URL \u3008https:\/\/www.dynata.com\/generate-new-data\/\u3009 (accessed 9.16.23)."},{"key":"10.1016\/j.dadr.2024.100235_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108278","article-title":"Individual and social network correlates of recent treatment for substance use disorders among persons who use drugs in Baltimore, MD (2014 \u2013 2017)","volume":"217","author":"Rudolph","year":"2020","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.dadr.2024.100235_bib16","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1080\/08897077.2013.804484","article-title":"I Heard About It from a Friend: Assessing Interest in Buprenorphine Treatment","volume":"35","author":"Fox","year":"2014","journal-title":"Subst. Abus."},{"key":"10.1016\/j.dadr.2024.100235_bib17","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.3711","article-title":"Association of racial\/ethnic segregation with treatment capacity for opioid use disorder in counties in the United States","volume":"3","author":"Goedel","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.dadr.2024.100235_bib18","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1521-0391.2012.12004.x","article-title":"Patient perspectives on choosing buprenorphine over methadone in an urban, equal-access system: reasons for choosing buprenorphine","volume":"22","author":"Gryczynski","year":"2013","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.dadr.2024.100235_bib19","unstructured":"Glanz, K., Rimer, B.K., & Viswanath, K. (Eds.). (2008). Health behavior and health education: Theory, research, and practice (4th ed. Chapter 9). Jossey-Bass."},{"key":"10.1016\/j.dadr.2024.100235_bib20","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1080\/10826080802293038","article-title":"Individual and social factors associated with participation in treatment programs for drug users","volume":"43","author":"Gyarmathy","year":"2008","journal-title":"Subst. Use Misuse"},{"key":"10.1016\/j.dadr.2024.100235_bib21","series-title":"Critical Perspectives on Addiction, Advances in Medical Sociology","first-page":"79","article-title":"Two tiers of biomedicalization: methadone, buprenorphine, and the racial politics of addiction treatment","author":"Hansen","year":"2012"},{"key":"10.1016\/j.dadr.2024.100235_bib22","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.drugalcdep.2016.03.028","article-title":"Buprenorphine and methadone treatment for opioid dependence by income, ethnicity and race of neighborhoods in New York City","volume":"164","author":"Hansen","year":"2016","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.dadr.2024.100235_bib23","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s11414-013-9341-3","article-title":"Variation in use of buprenorphine and methadone treatment by racial, ethnic, and income characteristics of residential social areas in New York City","volume":"40","author":"Hansen","year":"2013","journal-title":"J. Behav. Health Serv. Res"},{"key":"10.1016\/j.dadr.2024.100235_bib24","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.drugalcdep.2017.08.019","article-title":"The relationship between treatment accessibility and preference amongst out-of-treatment individuals who engage in non-medical prescription opioid use","volume":"180","author":"Huhn","year":"2017","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.dadr.2024.100235_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2022.108918","article-title":"A qualitative analysis of barriers to opioid agonist treatment for racial\/ethnic minoritized populations","volume":"144","author":"Husain","year":"2023","journal-title":"J. Subst. Abus. Treat."},{"key":"10.1016\/j.dadr.2024.100235_bib26","doi-asserted-by":"crossref","DOI":"10.2196\/11865","article-title":"Socioeconomic status and racial or ethnic differences in participation: web-based survey","volume":"8","author":"Jang","year":"2019","journal-title":"JMIR Res. Protoc."},{"key":"10.1016\/j.dadr.2024.100235_bib27","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jsat.2018.08.011","article-title":"Buprenorphine treatment formulations: Preferences among persons in opioid withdrawal management","volume":"94","author":"Kenney","year":"2018","journal-title":"J. Subst. Abus. Treat."},{"key":"10.1016\/j.dadr.2024.100235_bib28","article-title":"The role of social network support in treatment outcomes for medication for opioid use disorder: a systematic review","author":"Kumar","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.dadr.2024.100235_bib29","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1001\/jamapsychiatry.2019.0876","article-title":"Buprenorphine Treatment Divide by Race\/Ethnicity and Payment","volume":"76","author":"Lagisetty","year":"2019","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.dadr.2024.100235_bib30","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jsat.2019.06.001","article-title":"Brief video intervention to improve attitudes throughout medications for opioid use disorder in a correctional setting","volume":"104","author":"Lam","year":"2019","journal-title":"J. Subst. Abus. Treat."},{"key":"10.1016\/j.dadr.2024.100235_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2019.107732","article-title":"Prevalence and treatment of opioid use disorders among primary care patients in six health systems","volume":"207","author":"Lapham","year":"2020","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.dadr.2024.100235_bib32","first-page":"20","article-title":"Attitudes of primary care physicians toward prescribing buprenorphine: a narrative review","author":"Louie","year":"2019","journal-title":"BMC Fam. Pr."},{"key":"10.1016\/j.dadr.2024.100235_bib33","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1080\/10826084.2021.1975749","article-title":"Intervention Stigma toward Medications for Opioid Use Disorder: A Systematic Review","volume":"56","author":"Madden","year":"2021","journal-title":"Subst. Use Misuse"},{"key":"10.1016\/j.dadr.2024.100235_bib34","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s10597-017-0218-4","article-title":"Oxford House Residents\u2019 Attitudes Toward Medication Assisted Treatment Use in Fellow Residents","volume":"54","author":"Majer","year":"2018","journal-title":"Community Ment. Health J."},{"key":"10.1016\/j.dadr.2024.100235_bib35","doi-asserted-by":"crossref","DOI":"10.1017\/S2045796022000622","article-title":"Indirect social contact interventions to reduce mental health-related stigma in low- and middle-income countries: systematic review","volume":"31","author":"Makhmud","year":"2022","journal-title":"Epidemiol. Psychiatr. Sci."},{"key":"10.1016\/j.dadr.2024.100235_bib37","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.drugpo.2019.10.005","article-title":"Ambiguous identities of drugs and people: A scoping review of opioid-related stigma","volume":"74","author":"McCradden","year":"2019","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.dadr.2024.100235_bib38","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1111\/add.15032","article-title":"Mechanical Turk Data Collection in Addiction Research: Utility, Concerns and Best Practices","volume":"115","author":"Mellis","year":"2020","journal-title":"Addict. Abingdon Engl."},{"key":"10.1016\/j.dadr.2024.100235_bib39","series-title":"In Population-Based Survey Experiments","first-page":"54","article-title":"Chapter Four. Vignette Treatments","author":"Mutz","year":"2015"},{"key":"10.1016\/j.dadr.2024.100235_bib40","unstructured":"National Survey of Drug Use and Health (NSDUH) Releases | CBHSQ Data [WWW Document], 2020. URL \u3008https:\/\/www.samhsa.gov\/data\/release\/2020-national-survey-drug-use-and-health-nsduh-releases\u3009 (accessed 3.20.22)."},{"key":"10.1016\/j.dadr.2024.100235_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108649","article-title":"Familial perceptions of appropriate treatment types and goals for a family member who has opioid use disorder","volume":"221","author":"Nayak","year":"2021","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.dadr.2024.100235_bib42","unstructured":"National Institute on Drug Abuse (NIDA) | Treatment [Highlights], 2023. URL \u3008https:\/\/nida.nih.gov\/research-topics\/treatment\u3009 (accessed 4.10.2023)."},{"key":"10.1016\/j.dadr.2024.100235_bib43","unstructured":"Opioid overdose, 2024. World Health Organization. URL \u3008https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/opioid-overdose\u3009 (accessed 3.31.24)."},{"key":"10.1016\/j.dadr.2024.100235_bib44","unstructured":"Patten, E., Perrin, A., 2015. Who\u2019s left out in a Web-only survey and how it affects results. Pew Res. Cent. URL \u3008https:\/\/www.pewresearch.org\/fact-tank\/2015\/09\/22\/who-s-left-out-in-a-web-only-survey-and-how-it-affects-results\/\u3009(accessed 4.5.23).."},{"key":"10.1016\/j.dadr.2024.100235_bib45","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1080\/02791072.1991.10472226","article-title":"A brief history of methadone in the treatment of opioid dependence: a personal perspective","volume":"23","author":"Payte","year":"1991","journal-title":"J. Psychoact. Drugs"},{"key":"10.1016\/j.dadr.2024.100235_bib46","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12916-018-1244-y","article-title":"A systematic review of multi-level stigma interventions: state of the science and future directions","volume":"17","author":"Rao","year":"2019","journal-title":"BMC Med"},{"key":"10.1016\/j.dadr.2024.100235_bib47","unstructured":"R Core Team, 2021. R: A language and environment for statistical computing."},{"key":"10.1016\/j.dadr.2024.100235_bib48","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1001\/jamainternmed.2022.0761","article-title":"COVID-19 Vaccine Uptake and Intentions Following US Food and Drug Administration Approval of the Pfizer-BioNTech COVID-19 Vaccine","volume":"182","author":"Scherer","year":"2022","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.dadr.2024.100235_bib49","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.5734","article-title":"Assessment of Racial and Ethnic Disparities in the Use of Medication to Treat Opioid Use Disorder Among Pregnant Women in Massachusetts","volume":"3","author":"Schiff","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.dadr.2024.100235_bib50","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1080\/10550490802268835","article-title":"Attitudes Toward Buprenorphine and Methadone Among Opioid-Dependent Individuals","volume":"17","author":"Schwartz","year":"2008","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.dadr.2024.100235_bib51","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.socscimed.2009.10.033","article-title":"Socio-spatial stigmatization and the contested space of addiction treatment: Remapping strategies of opposition to the disorder of drugs","volume":"70","author":"Smith","year":"2010","journal-title":"Soc. Sci. Med."},{"key":"10.1016\/j.dadr.2024.100235_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108849","article-title":"Racial\/ethnic disparities in the use of medications for opioid use disorder (MOUD) and their effects on residential drug treatment outcomes in the US","volume":"226","author":"Stahler","year":"2021","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.dadr.2024.100235_bib53","unstructured":"SAMHSA, 2018. TIP 63: Medications for Opioid Use Disorder. URL \u3008https:\/\/store.samhsa.gov\/product\/tip-63-medications-opioid-use-disorder\/pep21-02-01-002\u3009. (accessed 4.10.2024)."},{"key":"10.1016\/j.dadr.2024.100235_bib54","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/S0140-6736(15)00298-6","article-title":"Evidence for effective interventions to reduce mental-health-related stigma\u00a0and discrimination","volume":"387","author":"Thornicroft","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.dadr.2024.100235_bib55","article-title":"\u201cDon\u2019t judge a book by its cover\u201d: a qualitative study of methadone patients\u2019 experiences of stigma","volume":"11","author":"Woo","year":"2017","journal-title":"Subst. Abus."}],"container-title":["Drug and Alcohol Dependence Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772724624000192?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772724624000192?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T07:13:32Z","timestamp":1718867612000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772724624000192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":54,"alternative-id":["S2772724624000192"],"URL":"https:\/\/doi.org\/10.1016\/j.dadr.2024.100235","relation":{},"ISSN":["2772-7246"],"issn-type":[{"type":"print","value":"2772-7246"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of a pilot brief educational intervention on preferences regarding treatments for opioid use disorder","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dadr.2024.100235","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100235"}}